Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2007; 13(15): 2198-2204
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2198
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2198
Group | Cell viability(%) | LDH nmol/min/106 cells | TBARS nmol/106 cells | GSHnmol/106 cells |
Control | 75 ± 5.97 | 0.157 ± 0.096 | 0.102 ± 0.018 | 13.0 ± 2.53 |
CCl4 | 35 ± 6.59f | 0.563 ± 0.098f | 0.304 ± 0.056f | 1.24 ± 0.43f |
1 μmol/L Lovastatin + CCl4 | 33 ± 4.99f | 0.342 ± 0.028da | 0.193 ± 0.004da | 1.40 ± 0.49f |
3 μmol/L Lovastatin + CCl4 | 42 ± 4.50d | 0.328 ± 0.041a | 0.170 ± 0.020a | 2.49 ± 0.10f |
5 μmol/L Lovastatin + CCl4 | 43 ± 7.77d | 0.291 ± 0.025a | 0.160 ± 0.014a | 6.55 ± 0.005fb |
10 μmol/L Lovastatin + CCl4 | 45 ± 1.52d | 0.239 ± 0.016a | 0.130 ± 0.041a | 7.50 ± 0.008db |
-
Citation: Krasteva A, Mitcheva M, Kondeva-Burdina M, Descatoire V.
In vitro study of lovastatin interactions with amiodarone and with carbon tetrachloride in isolated rat hepatocytes. World J Gastroenterol 2007; 13(15): 2198-2204 - URL: https://www.wjgnet.com/1007-9327/full/v13/i15/2198.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i15.2198